Rowan Researchers Develop Blood Test That Detects Early Alzheimer’s Disease
Rowan UniversityResearchers from Rowan University School of Osteopathic Medicine have announced the development of a blood test that leverages the body’s immune response system to detect early stage of Alzheimer’s disease with unparalleled accuracy. In a “proof of concept” study involving 236 subjects, the test demonstrated an overall accuracy, sensitivity and specificity rate of 100 percent in identifying subjects whose mild cognitive impairment (MCI) was actually caused by an early stage of Alzheimer’s disease.